Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12
Open Access
- 1 November 1994
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (5) , 905-907
- https://doi.org/10.1038/bjc.1994.418
Abstract
Frequent loss of heterozygosity (LOH) has been reported on 22q in ovarian carcinoma, implying the presence of a tumour-suppressor gene. The neurofibromatosis type 2 gene (NF2) at 22q12 is a plausible candidate. Analysis of 9 of the 17 exons of NF2 by single-strand conformational polymorphism (SSCP) in 67 ovarian carcinomas did not detect any somatic mutations, suggesting that NF2 is not involved in the pathogenesis of ovarian carcinoma. LOH data support this conclusion and that the putative tumour-suppressor gene lies distal to NF2, beyond D22S283.Keywords
This publication has 30 references indexed in Scilit:
- Mutation analysis of RASK and the ‘FLR exon’ of NF1 in sporadic ovarian carcinomaEuropean Journal Of Cancer, 1994
- Integrated human genome–wide maps constructed using the CEPH reference panelNature Genetics, 1994
- Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage mapNature Genetics, 1994
- Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomasNature Genetics, 1994
- Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22Human Mutation, 1994
- CA-repeat polymorphism at the D22S430 locus adjacent to NF2Human Molecular Genetics, 1993
- Allelic loss in ovarian cancerInternational Journal of Cancer, 1993
- Heterogeneity for Allelic Loss in Human Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Somatic mutations in the neurofibromatosis 1 gene in human tumorsCell, 1992
- Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coliNature, 1988